A Korean Post-Marketing Study of Abacavir/Dolutegravir/Lamivudine in Patients with HIV-1.

Sang-Kyu Shin Jung-Eun Cho Eun-Bin Lee Yeon Sook Kim Younggon Jung

Published in: Infection & chemotherapy (2023)

Results of this PMS study showed that abacavir/dolutegravir/lamivudine administered as highly active antiretroviral therapy was well tolerated and effective in patients with HIV-1 infection.

Keyphrases

antiretroviral therapy
hiv infected patients
hiv infected
hiv positive
human immunodeficiency virus
hiv aids
hepatitis c virus